Patricia Bitar
Directeur/Membre du Conseil chez Memgen, Inc.
Profil
Patricia L.
Bitar is currently the Director at Memgen, Inc. She previously worked as a Senior Audit Manager at Ernst & Young LLP from 1994 to 1998, Vice President & Controller at NuVasive, Inc. in 2014, Controller at Orexigen Therapeutics, Inc. from 2006 to 2008, CFO, Treasurer & Assistant Secretary at TRACON Pharmaceuticals, Inc. from 2014 to 2018, and Chief Financial Officer at Landos Biopharma, Inc. from 2021 to 2022.
Bitar received her undergraduate degree from Old Dominion University and her graduate degree from the University of West Florida.
Postes actifs de Patricia Bitar
| Sociétés | Poste | Début |
|---|---|---|
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Directeur/Membre du Conseil | - |
Anciens postes connus de Patricia Bitar
| Sociétés | Poste | Fin |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Directeur Financier/CFO | 15/05/2022 |
| TRACON PHARMACEUTICALS, INC. | Directeur Financier/CFO | 15/06/2018 |
| NUVASIVE, INC. | Comptroller/Controller/Auditor | 01/04/2014 |
| OREXIGEN THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/01/2008 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/1998 |
Formation de Patricia Bitar
| University of West Florida | Graduate Degree |
| Old Dominion University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA. | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Health Technology |